SEI INVESTMENTS CO - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 159 filers reported holding VIKING THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,638,061
-56.4%
30,897
-32.6%
0.00%
-66.7%
Q1 2024$3,756,340
+682.8%
45,809
+77.7%
0.01%
+500.0%
Q4 2023$479,875
-11.8%
25,786
-23.2%
0.00%0.0%
Q2 2023$544,105
-50.9%
33,566
-49.6%
0.00%
-50.0%
Q1 2023$1,108,474
+78.8%
66,575
+0.9%
0.00%
+100.0%
Q4 2022$620,115
+12302.3%
65,970
+8166.9%
0.00%
Q1 2019$5,000
-98.7%
798
-98.4%
0.00%
-100.0%
Q4 2018$386,000
+2657.1%
50,900
+6442.4%
0.00%
Q3 2018$14,000
-98.4%
778
-99.2%
0.00%
-100.0%
Q2 2018$878,00092,5650.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders